FSTL1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.607800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.190000E-01
Normal-vs-Stage2
7.102000E-01
Normal-vs-Stage3
5.872000E-01
Normal-vs-Stage4
4.926200E-01
Stage1-vs-Stage2
2.993200E-01
Stage1-vs-Stage3
2.570000E-01
Stage1-vs-Stage4
1.851810E-01
Stage2-vs-Stage3
4.960200E-01
Stage2-vs-Stage4
2.977000E-01
Stage3-vs-Stage4
8.592400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.694200E-01
Normal-vs-AfricanAmerican
6.803200E-01
Normal-vs-Asian
8.624800E-01
Caucasian-vs-AfricanAmerican
7.207600E-01
Caucasian-vs-Asian
3.636600E-01
AfricanAmerican-vs-Asian
3.976200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.673600E-01
Normal-vs-Female
6.174600E-01
Male-vs-Female
2.552600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.560000E-01
Normal-vs-Age(41-60Yrs)
4.477800E-01
Normal-vs-Age(61-80Yrs)
8.787200E-01
Normal-vs-Age(81-100Yrs)
8.864600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.172400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.608400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.095200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.835900E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
8.633900E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.869800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.109200E-01
Normal-vs-Daily Drinker
8.077600E-01
Normal-vs-Weekly Drinker
5.325800E-01
Normal-vs-Occasional Drinker
9.651400E-01
Normal-vs-Social Drinker
6.278400E-01
Non Drinker-vs-Daily Drinker
9.247400E-01
Non Drinker-vs-Weekly Drinker
8.027900E-02
Non Drinker-vs-Occasional Drinker
5.624600E-01
Non Drinker-vs-Social Drinker
1.311580E-01
Daily Drinker-vs-Weekly Drinker
7.479600E-02
Daily Drinker-vs-Occasional Drinker
5.955800E-01
Daily Drinker-vs-Social Drinker
1.747370E-01
Weekly Drinker-vs-Occasional Drinker
2.636000E-01
Weekly Drinker-vs-Social Drinker
8.616800E-01
Occasional Drinker-vs-Social Drinker
3.713400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.084200E-01
Normal-vs-Grade 2
6.890200E-01
Normal-vs-Grade 3
8.751000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.977100E-03
Grade 1-vs-Grade 3
7.460100E-02
Grade 1-vs-Grade 4
7.084200E-01
Grade 2-vs-Grade 3
2.911600E-01
Grade 2-vs-Grade 4
6.890200E-01
Grade 3-vs-Grade 4
8.751000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.911000E-01
Normal-vs-NonDiabetic
8.906000E-01
Diabetic-vs-NonDiabetic
6.149800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.432800E-01
Normal-vs-NoPancreatitis
8.340400E-01
Pancreatitis-vs-NoPancreatitis
9.010200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.390000E-01
Normal-vs-N1
6.581000E-01
N0-vs-N1
2.251200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.394400E-01
Normal-vs-TP53-NonMutant
8.672800E-01
TP53-Mutant-vs-TP53-NonMutant
7.402000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
